LEADER 01730oam  2200469   450 
001 9910717377703321
005 20210320214614.0
035   $a(CKB)4100000011741655
035   $a(OCoLC)1241081605
035   $a(EXLCZ)994100000011741655
100   $a20210310d2020      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPriced out of a lifesaving drug $ethe human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
210  1$aWashington :$cU.S. Government Publishing Office,$d2020.
215   $a1 online resource (v, 97 pages) $cillustrations
300   $a"Serial No. 116-21."
320   $aIncludes bibliographical references.
517   $aPriced out of a Lifesaving Drug
606   $aInsulin$xCost control
606   $aPrescription pricing$xGovernment policy$zUnited States
606   $aPharmaceutical industry$zUnited States
606   $aDrugs$zUnited States$xCost control
606   $aDrugs$xPrices$xGovernment policy$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aInsulin$xCost control.
615  0$aPrescription pricing$xGovernment policy
615  0$aPharmaceutical industry
615  0$aDrugs$xCost control.
615  0$aDrugs$xPrices$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910717377703321
996   $aPriced out of a lifesaving drug$93442051
997   $aUNINA